Oseltamivir (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Oseltamivir" in Serbian language version.

refsWebsite

Global rank Serbian rank

14nih.gov

4^th place

8^th place

14doi.org

2^nd place

4^th place

3drugs.com

399^th place

744^th place

3web.archive.org

1^st place

3harvard.edu

18^th place

28^th place

1cdc.gov

218^th place

138^th place

1europa.eu

68^th place

107^th place

1nice.org.uk

3,258^th place

1,880^th place

1idsociety.org

low place

1theatlantic.com

228^th place

822^nd place

1who.int

195^th place

154^th place

1fda.gov

447^th place

925^th place

1msh.org

low place

1medicaid.gov

low place

cdc.gov (Global: 218^th place; Serbian: 138^th place)

„CDC Online Newsroom - "Have You Heard?" Archive: 2014 - Influenza A Variant Virus”. www.cdc.gov. 10. 4. 2014. Архивирано из оригинала 18. 01. 2017. г. Приступљено 16. 1. 2017.

doi.org (Global: 2^nd place; Serbian: 4^th place)

Davies, BE (2010). „Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations.”. The Journal of Antimicrobial Chemotherapy. 65 Suppl 2 (Suppl 2): ii5—ii10. PMC 2835511 . PMID 20215135. doi:10.1093/jac/dkq015.
Butler, Declan (2014). „Tamiflu report comes under fire”. Nature. 508 (7497): 439—440. Bibcode:2014Natur.508..439B. PMID 24759392. doi:10.1038/508439a.
Coenen, B; Van Puyenbroeck, K; Verhoeven, V; Vermeire, E; Coenen, S (2013). Jefferson, Tom, ур. „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS ONE. 8 (4): e60348. Bibcode:2013PLoSO...860348M. PMC 3614893 . PMID 23565231. doi:10.1371/journal.pone.0060348 .
Ebell, MH; Call, M; Shinholser, J (2013). „Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials”. Family Practice. 30 (2): 125—33. PMID 22997224. doi:10.1093/fampra/cms059.
Okoli, George N.; Otete, Harmony E.; Beck, Charles R.; Nguyen-Van-Tam, Jonathan S.; Schmidt, Robert Lane (9. 12. 2014). „Use of Neuraminidase Inhibitors for Rapid Containment of Influenza: A Systematic Review and Meta-Analysis of Individual and Household Transmission Studies”. PLOS ONE. 9 (12): e113633. Bibcode:2014PLoSO...9k3633O. PMC 4260958 . PMID 25490762. doi:10.1371/journal.pone.0113633 .
Wang K, Shun-Shin M, Gill P, Perera R, Harnden A (2012). Harnden A, ур. „Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)”. Cochrane Database Syst Rev. 2012 (4): CD002744. PMC 6599832 . PMID 22513907. doi:10.1002/14651858.CD002744.pub4.
Jefferson, T; Jones, M; Doshi, P; Spencer, EA; Onakpoya, I; Heneghan, CJ (9. 4. 2014). „Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.”. BMJ (Clinical Research Ed.). 348: g2545. PMC 3981975 . PMID 24811411. doi:10.1136/bmj.g2545.
Agrawal, R; Rewatkar, PV; Kokil, GR; Verma, A; Kalra, A (2010). „Oseltamivir: a first line defense against swine flu.”. Medicinal Chemistry (Shariqah (United Arab Emirates)). 6 (4): 247—51. PMID 20843284. doi:10.2174/1573406411006040247.
Chokephaibulkit K, Uiprasertkul M, Puthavathana P, Chearskul P, Auewarakul P, Dowell SF, Vanprapar N: A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J. Chokephaibulkit, K.; Uiprasertkul, M.; Puthavathana, P.; Chearskul, P.; Auewarakul, P.; Dowell, S. F.; Vanprapar, N. (фебруар 2005). „A child with avian influenza A (H5N1) infection”. The Pediatric Infectious Disease Journal. 24 (2): 162—6. PMID 15702046. doi:10.1097/01.inf.0000151037.25237.1e.
de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J: Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. De Jong, M. D.; Tran, T. T.; Truong, H. K.; Vo, M. H.; Smith, G. J.; Nguyen, V. C.; Bach, V. C.; Phan, T. Q.; Do, Q. H.; Guan, Y.; Peiris, J. S.; Tran, T. H.; Farrar, J. (децембар 2005). „Oseltamivir resistance during treatment of influenza A (H5N1) infection”. The New England Journal of Medicine. 353 (25): 2667—72. PMID 16371632. doi:10.1056/NEJMoa054512.
Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y: Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 28-Sep 3;Kiso, M.; Mitamura, K.; Sakai-Tagawa, Y.; Shiraishi, K.; Kawakami, C.; Kimura, K.; Hayden, F. G.; Sugaya, N.; Kawaoka, Y. (август 2004). „Resistant influenza a viruses in children treated with oseltamivir: Descriptive study”. Lancet (London, England). 364 (9436): 759—65. PMID 15337401. doi:10.1016/S0140-6736(04)16934-1.
Ward P, Small I, Smith J, Suter P, Dutkowski R: Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005 Feb;55 Suppl 1:i5-i21. Ward, P.; Small, I.; Smith, J.; Suter, P.; Dutkowski, R. (2005). „Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic”. The Journal of Antimicrobial Chemotherapy. 55 Suppl 1: i5—i21. PMID 15709056. doi:10.1093/jac/dki018.
Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.

drugs.com (Global: 399^th place; Serbian: 744^th place)

„Tamiflu - Drugs.com”. www.drugs.com. Приступљено 16. 1. 2017.
„Oseltamivir Phosphate”. The American Society of Health-System Pharmacists. Приступљено 8. 1. 2017.
„Oseltamivir (Tamiflu) Use During Pregnancy”. www.drugs.com. Приступљено 16. 1. 2017.

europa.eu (Global: 68^th place; Serbian: 107^th place)

ecdc.europa.eu

European Centre for Disease Prevention and Control (2. 6. 2014). „New and updated evaluations of neuraminidase inhibitors for preventing and treating influenza published”.

fda.gov (Global: 447^th place; Serbian: 925^th place)

„The FDA approves first generic version of widely used influenza drug, Tamiflu”. FDA. 4. 8. 2016. Приступљено 6. 8. 2016.

harvard.edu (Global: 18^th place; Serbian: 28^th place)

adsabs.harvard.edu

Butler, Declan (2014). „Tamiflu report comes under fire”. Nature. 508 (7497): 439—440. Bibcode:2014Natur.508..439B. PMID 24759392. doi:10.1038/508439a.
Coenen, B; Van Puyenbroeck, K; Verhoeven, V; Vermeire, E; Coenen, S (2013). Jefferson, Tom, ур. „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS ONE. 8 (4): e60348. Bibcode:2013PLoSO...860348M. PMC 3614893 . PMID 23565231. doi:10.1371/journal.pone.0060348 .
Okoli, George N.; Otete, Harmony E.; Beck, Charles R.; Nguyen-Van-Tam, Jonathan S.; Schmidt, Robert Lane (9. 12. 2014). „Use of Neuraminidase Inhibitors for Rapid Containment of Influenza: A Systematic Review and Meta-Analysis of Individual and Household Transmission Studies”. PLOS ONE. 9 (12): e113633. Bibcode:2014PLoSO...9k3633O. PMC 4260958 . PMID 25490762. doi:10.1371/journal.pone.0113633 .

idsociety.org (Global: low place; Serbian: low place)

„IDSA : IDSA Continues to Recommend Antivirals for Influenza”. Архивирано из оригинала 24. 04. 2014. г. Приступљено 24. 4. 2014.

medicaid.gov (Global: low place; Serbian: low place)

data.medicaid.gov

„NADAC as of 2016-12-07 | Data.Medicaid.gov”. Centers for Medicare and Medicaid Services. Архивирано из оригинала 21. 12. 2016. г. Приступљено 16. 1. 2017.

msh.org (Global: low place; Serbian: low place)

erc.msh.org

„Oseltamivir”. International Drug Price Indicator Guide. Приступљено 30. 7. 2016. ^{[мртва веза]}

nice.org.uk (Global: 3,258^th place; Serbian: 1,880^th place)

„Amantadine, oseltamivir and zanamivir for the treatment of influenza”. www.nice.org.uk. NICE. 25. 2. 2009. Приступљено 16. 1. 2017.

nih.gov (Global: 4^th place; Serbian: 8^th place)

ncbi.nlm.nih.gov

Davies, BE (2010). „Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations.”. The Journal of Antimicrobial Chemotherapy. 65 Suppl 2 (Suppl 2): ii5—ii10. PMC 2835511 . PMID 20215135. doi:10.1093/jac/dkq015.
Butler, Declan (2014). „Tamiflu report comes under fire”. Nature. 508 (7497): 439—440. Bibcode:2014Natur.508..439B. PMID 24759392. doi:10.1038/508439a.
Coenen, B; Van Puyenbroeck, K; Verhoeven, V; Vermeire, E; Coenen, S (2013). Jefferson, Tom, ур. „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS ONE. 8 (4): e60348. Bibcode:2013PLoSO...860348M. PMC 3614893 . PMID 23565231. doi:10.1371/journal.pone.0060348 .
Ebell, MH; Call, M; Shinholser, J (2013). „Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials”. Family Practice. 30 (2): 125—33. PMID 22997224. doi:10.1093/fampra/cms059.
Okoli, George N.; Otete, Harmony E.; Beck, Charles R.; Nguyen-Van-Tam, Jonathan S.; Schmidt, Robert Lane (9. 12. 2014). „Use of Neuraminidase Inhibitors for Rapid Containment of Influenza: A Systematic Review and Meta-Analysis of Individual and Household Transmission Studies”. PLOS ONE. 9 (12): e113633. Bibcode:2014PLoSO...9k3633O. PMC 4260958 . PMID 25490762. doi:10.1371/journal.pone.0113633 .
Wang K, Shun-Shin M, Gill P, Perera R, Harnden A (2012). Harnden A, ур. „Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)”. Cochrane Database Syst Rev. 2012 (4): CD002744. PMC 6599832 . PMID 22513907. doi:10.1002/14651858.CD002744.pub4.
Jefferson, T; Jones, M; Doshi, P; Spencer, EA; Onakpoya, I; Heneghan, CJ (9. 4. 2014). „Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.”. BMJ (Clinical Research Ed.). 348: g2545. PMC 3981975 . PMID 24811411. doi:10.1136/bmj.g2545.
Agrawal, R; Rewatkar, PV; Kokil, GR; Verma, A; Kalra, A (2010). „Oseltamivir: a first line defense against swine flu.”. Medicinal Chemistry (Shariqah (United Arab Emirates)). 6 (4): 247—51. PMID 20843284. doi:10.2174/1573406411006040247.
Chokephaibulkit K, Uiprasertkul M, Puthavathana P, Chearskul P, Auewarakul P, Dowell SF, Vanprapar N: A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J. Chokephaibulkit, K.; Uiprasertkul, M.; Puthavathana, P.; Chearskul, P.; Auewarakul, P.; Dowell, S. F.; Vanprapar, N. (фебруар 2005). „A child with avian influenza A (H5N1) infection”. The Pediatric Infectious Disease Journal. 24 (2): 162—6. PMID 15702046. doi:10.1097/01.inf.0000151037.25237.1e.
de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J: Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. De Jong, M. D.; Tran, T. T.; Truong, H. K.; Vo, M. H.; Smith, G. J.; Nguyen, V. C.; Bach, V. C.; Phan, T. Q.; Do, Q. H.; Guan, Y.; Peiris, J. S.; Tran, T. H.; Farrar, J. (децембар 2005). „Oseltamivir resistance during treatment of influenza A (H5N1) infection”. The New England Journal of Medicine. 353 (25): 2667—72. PMID 16371632. doi:10.1056/NEJMoa054512.
Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y: Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 28-Sep 3;Kiso, M.; Mitamura, K.; Sakai-Tagawa, Y.; Shiraishi, K.; Kawakami, C.; Kimura, K.; Hayden, F. G.; Sugaya, N.; Kawaoka, Y. (август 2004). „Resistant influenza a viruses in children treated with oseltamivir: Descriptive study”. Lancet (London, England). 364 (9436): 759—65. PMID 15337401. doi:10.1016/S0140-6736(04)16934-1.
Ward P, Small I, Smith J, Suter P, Dutkowski R: Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005 Feb;55 Suppl 1:i5-i21. Ward, P.; Small, I.; Smith, J.; Suter, P.; Dutkowski, R. (2005). „Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic”. The Journal of Antimicrobial Chemotherapy. 55 Suppl 1: i5—i21. PMID 15709056. doi:10.1093/jac/dki018.
Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.

theatlantic.com (Global: 228^th place; Serbian: 822^nd place)

Brownlee, Shannon (19. 2. 2013). „Tamiflu: Myth and Misconception”. The Atlantic. Приступљено 7. 12. 2014.

web.archive.org (Global: 1^st place; Serbian: 1^st place)

„CDC Online Newsroom - "Have You Heard?" Archive: 2014 - Influenza A Variant Virus”. www.cdc.gov. 10. 4. 2014. Архивирано из оригинала 18. 01. 2017. г. Приступљено 16. 1. 2017.
„IDSA : IDSA Continues to Recommend Antivirals for Influenza”. Архивирано из оригинала 24. 04. 2014. г. Приступљено 24. 4. 2014.
„NADAC as of 2016-12-07 | Data.Medicaid.gov”. Centers for Medicare and Medicaid Services. Архивирано из оригинала 21. 12. 2016. г. Приступљено 16. 1. 2017.

who.int (Global: 195^th place; Serbian: 154^th place)

„WHO Model List of Essential Medicines (19th List)” (PDF). World Health Organization. 2015. Приступљено 8. 12. 2016.

Oseltamivir (Serbian Wikipedia)

cdc.gov (Global: 218th place; Serbian: 138th place)

doi.org (Global: 2nd place; Serbian: 4th place)

drugs.com (Global: 399th place; Serbian: 744th place)

europa.eu (Global: 68th place; Serbian: 107th place)

ecdc.europa.eu

fda.gov (Global: 447th place; Serbian: 925th place)

harvard.edu (Global: 18th place; Serbian: 28th place)

adsabs.harvard.edu

idsociety.org (Global: low place; Serbian: low place)

medicaid.gov (Global: low place; Serbian: low place)

data.medicaid.gov

msh.org (Global: low place; Serbian: low place)

erc.msh.org

nice.org.uk (Global: 3,258th place; Serbian: 1,880th place)

nih.gov (Global: 4th place; Serbian: 8th place)

ncbi.nlm.nih.gov

theatlantic.com (Global: 228th place; Serbian: 822nd place)

web.archive.org (Global: 1st place; Serbian: 1st place)

who.int (Global: 195th place; Serbian: 154th place)

cdc.gov (Global: 218^th place; Serbian: 138^th place)

doi.org (Global: 2^nd place; Serbian: 4^th place)

drugs.com (Global: 399^th place; Serbian: 744^th place)

europa.eu (Global: 68^th place; Serbian: 107^th place)

fda.gov (Global: 447^th place; Serbian: 925^th place)

harvard.edu (Global: 18^th place; Serbian: 28^th place)

nice.org.uk (Global: 3,258^th place; Serbian: 1,880^th place)

nih.gov (Global: 4^th place; Serbian: 8^th place)

theatlantic.com (Global: 228^th place; Serbian: 822^nd place)

web.archive.org (Global: 1^st place; Serbian: 1^st place)

who.int (Global: 195^th place; Serbian: 154^th place)